| 1 | [SID103167698] | Active | Ki | 0.18 | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay [AID407366, Type: Literature] | Fatty acid-binding protein, liver [gi:119810] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | Ki | 0.18 [uM] | | BioAssay | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | | AID | 407366 | | BioAssay type | Literature | | Target | Fatty acid-binding protein, liver [gi:119810] | | PubMed | 18533710 | | Data Table |  |
|
| 2 | [SID103167698] | Active | Ki | 0.185 | Displacement of 1,8-ANS from aFABP by fluorescence based-assay [AID307907, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | Ki | 0.185 [uM] | | BioAssay | Displacement of 1,8-ANS from aFABP by fluorescence based-assay | | AID | 307907 | | BioAssay type | Literature | | Target | | | PubMed | 17502136 | | Data Table |  |
|
| 3 | [SID103167698] | Active | Kd | 0.2 | Binding affinity to L-FABP high binding affinity site by titration calorimetry method [AID407370, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | Kd | 0.2 [uM] | | BioAssay | Binding affinity to L-FABP high binding affinity site by titration calorimetry method | | AID | 407370 | | BioAssay type | Literature | | Target | | | PubMed | 18533710 | | Data Table |  |
|
| 4 | [SID103167698] | Active | Ki | 0.248 | Displacement of 1,8-ANS from eFABP by fluorescence based-assay [AID307909, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | Ki | 0.248 [uM] | | BioAssay | Displacement of 1,8-ANS from eFABP by fluorescence based-assay | | AID | 307909 | | BioAssay type | Literature | | Target | | | PubMed | 17502136 | | Data Table |  |
|
| 5 | [SID103167698] | Active | Kd | 0.9 | Binding affinity to L-FABP low binding affinity site by titration calorimetry method [AID407371, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | Kd | 0.9 [uM] | | BioAssay | Binding affinity to L-FABP low binding affinity site by titration calorimetry method | | AID | 407371 | | BioAssay type | Literature | | Target | | | PubMed | 18533710 | | Data Table |  |
|
| 6 | [SID103167698] | Active | Ki | 2.9 | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP low binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay [AID407369, Type: Literature] | Fatty acid-binding protein, liver [gi:119810] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | Ki | 2.9 [uM] | | BioAssay | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP low binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | | AID | 407369 | | BioAssay type | Literature | | Target | Fatty acid-binding protein, liver [gi:119810] | | PubMed | 18533710 | | Data Table |  |
|
| 7 | [SID103167698] | Active | GI50 | 10 | Growth inhibitory activity against human cancer cell line in the NCI?s anticancer drug screening program [AID247402, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | GI50 | 10 [uM] | | BioAssay | Growth inhibitory activity against human cancer cell line in the NCI?s anticancer drug screening program | | AID | 247402 | | BioAssay type | Literature | | Target | | | PubMed | 15743190 | | Data Table |  |
|
| 8 | [SID26732603] | Active | EC50 | 10.41 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | EC50 | 10.41 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 9 | [SID26732603] | Active | EC50 | 10.41 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | EC50 | 10.41 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 10 | [SID26732603] | Active | EC50 | 10.41 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | EC50 | 10.41 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 11 | [SID26732603] | Active | EC50 | 10.41 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | EC50 | 10.41 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 12 | [SID26732603] | Active | EC50 | 10.41 | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents [AID2121, Type: confirmatory] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | EC50 | 10.41 [uM] | | BioAssay | Confirmation Dose Response screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 2121 | | BioAssay type | confirmatory | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 13 | [SID17388831] | Active | Potency | 19.9526 | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 [AID893, Type: confirmatory] | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17388831 | | CID | 445639 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4 | | AID | 893 | | BioAssay type | confirmatory | | Target | Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310] | | PubMed | | | Data Table |  |
|
| 14 | [SID103167698] | Active | IC50 | 21 | Inhibition of amidolytic activity of human recombinant soluble tissue factor/human factor 7a preincubated with factor 7a for 90 mins [AID402798, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | IC50 | 21 [uM] | | BioAssay | Inhibition of amidolytic activity of human recombinant soluble tissue factor/human factor 7a preincubated with factor 7a for 90 mins | | AID | 402798 | | BioAssay type | Literature | | Target | | | PubMed | 9834151 | | Data Table |  |
|
| 15 | [SID103167698] | Active | Ki | 22 | Binding affinity to soybean LO1 [AID455092, Type: Literature] | Seed linoleate 13S-lipoxygenase-1 [gi:126398] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | Ki | 22 [uM] | | BioAssay | Binding affinity to soybean LO1 | | AID | 455092 | | BioAssay type | Literature | | Target | Seed linoleate 13S-lipoxygenase-1 [gi:126398] | | PubMed | 19716306 | | Data Table |  |
|
| 16 | [SID103167698] | Active | IC50 | 26.1 | Displacement of 8-anilino-1-naphthalene-sulfonic acid from human His-FABP4 expressed in Escherichia coli BL21 (DE3) cells after 3 mins [AID483947, Type: Literature] | Fatty acid-binding protein, adipocyte [gi:119781] |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | IC50 | 26.1 [uM] | | BioAssay | Displacement of 8-anilino-1-naphthalene-sulfonic acid from human His-FABP4 expressed in Escherichia coli BL21 (DE3) cells after 3 mins | | AID | 483947 | | BioAssay type | Literature | | Target | Fatty acid-binding protein, adipocyte [gi:119781] | | PubMed | 20471252 | | Data Table |  |
|
| 17 | [SID26752911] | Active | Potency | 29.8554 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26752911 | | CID | 445639 | | Outcome | Active | | Potency | 29.8554 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 18 | [SID103167698] | Active | IC50 | 30 | Inhibition of amidolytic activity of human recombinant soluble tissue factor/human factor 7a preincubated with factor 7a for 15 mins [AID402797, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | IC50 | 30 [uM] | | BioAssay | Inhibition of amidolytic activity of human recombinant soluble tissue factor/human factor 7a preincubated with factor 7a for 15 mins | | AID | 402797 | | BioAssay type | Literature | | Target | | | PubMed | 9834151 | | Data Table |  |
|
| 19 | [SID103167698] | Active | IC50 | 31 | Inhibition of DNA topoisomerase 1 [AID361445, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | IC50 | 31 [uM] | | BioAssay | Inhibition of DNA topoisomerase 1 | | AID | 361445 | | BioAssay type | Literature | | Target | | | PubMed | 12444712 | | Data Table |  |
|
| 20 | [SID26752911] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26752911 | | CID | 445639 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 21 | [SID26752911] | Active | Potency | 31.6228 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26752911 | | CID | 445639 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 22 | [SID103167698] | Active | IC50 | 32.7 | Inhibition of aromatase in human placental microsomes by radiometric method [AID376617, Type: Literature] | Cytochrome P450 19A1 [gi:117293] |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | IC50 | 32.7 [uM] | | BioAssay | Inhibition of aromatase in human placental microsomes by radiometric method | | AID | 376617 | | BioAssay type | Literature | | Target | Cytochrome P450 19A1 [gi:117293] | | PubMed | 16643058 | | Data Table |  |
|
| 23 | [SID17388831] | Active | Potency | 35.4813 | qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway [AID651778, Type: confirmatory] | Peroxisome proliferator-activated receptor alpha [gi:3041727] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17388831 | | CID | 445639 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway | | AID | 651778 | | BioAssay type | confirmatory | | Target | Peroxisome proliferator-activated receptor alpha [gi:3041727] | | PubMed | | | Data Table |  |
|
| 24 | [SID17388831] | Active | Potency | 35.4813 | qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway [AID651778, Type: confirmatory] | Peroxisome proliferator-activated receptor alpha [gi:3041727] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17388831 | | CID | 445639 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway | | AID | 651778 | | BioAssay type | confirmatory | | Target | Peroxisome proliferator-activated receptor alpha [gi:3041727] | | PubMed | | | Data Table |  |
|
| 25 | [SID144204637] | Active | Potency | 35.4813 | qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway [AID651778, Type: confirmatory] | Peroxisome proliferator-activated receptor alpha [gi:3041727] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 144204637 | | CID | 445639 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway | | AID | 651778 | | BioAssay type | confirmatory | | Target | Peroxisome proliferator-activated receptor alpha [gi:3041727] | | PubMed | | | Data Table |  |
|
| 26 | [SID144204637] | Active | Potency | 35.4813 | qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway [AID651778, Type: confirmatory] | Peroxisome proliferator-activated receptor alpha [gi:3041727] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 144204637 | | CID | 445639 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway | | AID | 651778 | | BioAssay type | confirmatory | | Target | Peroxisome proliferator-activated receptor alpha [gi:3041727] | | PubMed | | | Data Table |  |
|
| 27 | [SID26752911] | Active | Potency | 35.4813 | Inhibitors of USP1/UAF1: Pilot qHTS [AID504865, Type: confirmatory] | USP1 protein [Homo sapiens] [gi:118600387] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26752911 | | CID | 445639 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | Inhibitors of USP1/UAF1: Pilot qHTS | | AID | 504865 | | BioAssay type | confirmatory | | Target | USP1 protein [Homo sapiens] [gi:118600387] | | PubMed | | | Data Table |  |
|
| 28 | [SID26732603] | Active | Potency | 89.1251 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | Potency | 89.1251 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 29 | [SID46392022] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Human Serum Albumin Complexed With Cis-9-Octadecenoic Acid (Oleic Acid) [gi:18158774] |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 46392022 | | CID | 445639 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Human Serum Albumin Complexed With Cis-9-Octadecenoic Acid (Oleic Acid) [gi:18158774] | | PubMed | 11743713 | | Data Table |  |
|
| 30 | [SID46391972] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Toward Changing Specificity: Adipocyte Lipid Binding Protein Mutant, Oleic Acid Bound Form [gi:33356927] |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 46391972 | | CID | 445639 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Toward Changing Specificity: Adipocyte Lipid Binding Protein Mutant, Oleic Acid Bound Form [gi:33356927] | | PubMed | 14594993 | | Data Table |  |
|
| 31 | [SID26732603] | Active | | | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID602261, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 602261 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 32 | [SID26732603] | Active | | | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID602261, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 602261 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 33 | [SID26732603] | Active | | | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay [AID602261, Type: screening] | FASN gene product [Homo sapiens] [gi:41872631] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay | | AID | 602261 | | BioAssay type | screening | | Target | FASN gene product [Homo sapiens] [gi:41872631] | | PubMed | | | Data Table |  |
|
| 34 | [SID26732603] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 35 | [SID26732603] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 36 | [SID46393429] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Schistosoma Mansoni Fatty Acid Binding Protein In Complex With Oleic Acid [gi:55670477] |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 46393429 | | CID | 445639 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Schistosoma Mansoni Fatty Acid Binding Protein In Complex With Oleic Acid [gi:55670477] | | PubMed | 18093984 | | Data Table |  |
|
| 37 | [SID46392136] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, 1.4 Angstroms Structural Studies On Human Muscle Fatty Acid Binding Protein: Binding Intera [gi:157831354] |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 46392136 | | CID | 445639 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, 1.4 Angstroms Structural Studies On Human Muscle Fatty Acid Binding Protein: Binding Intera [gi:157831354] | | PubMed | 7922029 | | Data Table |  |
|
| 38 | [SID103167698] | Active | | | Binding affinity to enterotoxigenic Escherichia coli 12566 heat-labile enterotoxin assessed as inhibition of heat-labile enterotoxin binding to ganglioside GM1 receptor [AID423137, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | BioAssay | Binding affinity to enterotoxigenic Escherichia coli 12566 heat-labile enterotoxin assessed as inhibition of heat-labile enterotoxin binding to ganglioside GM1 receptor | | AID | 423137 | | BioAssay type | Literature | | Target | | | PubMed | 17954701 | | Data Table |  |
|
| 39 | [SID103167698] | Active | IC50 | | Inhibition of FAAH [AID346660, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103167698 | | CID | 445639 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Inhibition of FAAH | | AID | 346660 | | BioAssay type | Literature | | Target | | | PubMed | 18983142 | | Data Table |  |
|
| 40 | [SID17388831] | Active | | | qHTS Assay for Tau Filament Binding [AID596, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17388831 | | CID | 445639 | | Outcome | Active | | BioAssay | qHTS Assay for Tau Filament Binding | | AID | 596 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 41 | [SID17388831] | Active | | | qHTS Assay for Tau Filament Binding [AID596, Type: confirmatory] | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17388831 | | CID | 445639 | | Outcome | Active | | BioAssay | qHTS Assay for Tau Filament Binding | | AID | 596 | | BioAssay type | confirmatory | | Target | Microtubule-associated protein tau [Homo sapiens] [gi:92096784] | | PubMed | | | Data Table |  |
|
| 42 | [SID26732603] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 43 | [SID26732603] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 44 | [SID26732603] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 45 | [SID26732603] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 46 | [SID26732603] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 47 | [SID26732603] | Active | | | Counter screen assay of the parental CHO cells for identification of compounds that potentiate KCNQ1 potassium channels [AID493006, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | Counter screen assay of the parental CHO cells for identification of compounds that potentiate KCNQ1 potassium channels | | AID | 493006 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 48 | [SID26732603] | Active | | | Validation assay for identification of compounds that potentiate KCNQ1 potassium channels [AID493007, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that potentiate KCNQ1 potassium channels | | AID | 493007 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 49 | [SID26732603] | Active | | | Specificity screen against KCNQ1 for compounds that potentiate KCNQ2 potassium channels [AID2283, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | Specificity screen against KCNQ1 for compounds that potentiate KCNQ2 potassium channels | | AID | 2283 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 50 | [SID26732603] | Active | | | uHTS of Mcl-1/Noxa interaction inhibitors [AID1022, Type: screening] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26732603 | | CID | 445639 | | Outcome | Active | | BioAssay | uHTS of Mcl-1/Noxa interaction inhibitors | | AID | 1022 | | BioAssay type | screening | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|